- Patent portfolio secures innovation for the future of heart replacement - TUCSON, Ariz., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), ...
The maker of the FDA’s only approved total artificial heart has outlined plans to go public, with a $12 million IPO, according to Renaissance Capital. Picard Medical, which owns and operates the ...
Picard Medical (PMI), the developer of the SynCardia artificial heart, disclosed this week its plans to seek a public listing on the New York Stock Exchange under the ticker symbol PMI to raise as ...
Shares of Picard Medical (NYSE:PMI) climbed more than 50% when the Tucson, Arizona-based artificial heart developer began trading as a public company on Friday following an IPO priced at $4.00 per ...